Jan 1, 2023 Happy New Year 2023 The Macular Degeneration Association wanted to wish everyone a very Happy 2023. Apr 16, 2024 Treatment challenges in patients with nAMD Treatment challenges in patients with nAMD Apr 16, 2024 Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410 Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410 Apr 15, 2024 New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain